Article Versions Notes

Xu C, Zhong Q, Yu N, Zhang X, Yang K, Liu H, Cai M, Zheng Y. GRK5 as a Novel Therapeutic Target for Immune Evasion in Testicular Cancer: Insights from Multi-Omics Analysis and Immunotherapeutic Validation. Biomedicines. 2025; 13(7):1775. https://doi.org/10.3390/biomedicines13071775

Xu, Congcong, Qifeng Zhong, Nengfeng Yu, Xuqiang Zhang, Kefan Yang, Hao Liu, Ming Cai, and Yichun Zheng. 2025. "GRK5 as a Novel Therapeutic Target for Immune Evasion in Testicular Cancer: Insights from Multi-Omics Analysis and Immunotherapeutic Validation" Biomedicines 13, no. 7: 1775. https://doi.org/10.3390/biomedicines13071775

Xu, C., Zhong, Q., Yu, N., Zhang, X., Yang, K., Liu, H., Cai, M., & Zheng, Y. (2025). GRK5 as a Novel Therapeutic Target for Immune Evasion in Testicular Cancer: Insights from Multi-Omics Analysis and Immunotherapeutic Validation. Biomedicines, 13(7), 1775. https://doi.org/10.3390/biomedicines13071775